Connecting you to content on EBSCOhost

Works matching IS 08991987 AND DT 2004 AND VI 41 AND IP 3

Results: 5

1

Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her‐2/neu (erbB‐2) oncogene‐induced malignant transformation.

Published in:

Molecular Carcinogenesis, 2004, v. 41, n. 3, p. 164, doi. 10.1002/mc.20054

By:

Javier A. Menendez;
Inderjit Mehmi;
Vishal A. Verma;
Poh K. Teng;
Ruth Lupu

Publication type:

Article

2

Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters.

Published in:

Molecular Carcinogenesis, 2004, v. 41, n. 3, p. 125, doi. 10.1002/mc.20049

By:

Mark D. Gustavson;
Howard C. Crawford;
Barbara Fingleton;
Lynn M. Matrisian

Publication type:

Article

3

Suppression of inducible nitric oxide synthase and cyclooxygenase‐2 in downregulating nuclear factor‐kappa B pathway by Garcinol.

Published in:

Molecular Carcinogenesis, 2004, v. 41, n. 3, p. 140, doi. 10.1002/mc.20050

By:

Chiung‐Ho Liao;
Shengmin Sang;
Yu‐Chih Liang;
Chi‐Tang Ho;
Jen‐Kun Lin

Publication type:

Article

4

Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events.

Published in:

Molecular Carcinogenesis, 2004, v. 41, n. 3, p. 150, doi. 10.1002/mc.20051

By:

F.M. Sirotnak;
Yuhong She;
Nushmia Z. Khokhar;
Paula Hayes;
William Gerald;
Howard I. Scher

Publication type:

Article

5

Phase II enzyme inducer, sulforaphane, inhibits UVB‐induced AP‐1 activation in human keratinocytes by a novel mechanism.

Published in:

Molecular Carcinogenesis, 2004, v. 41, n. 3, p. 179, doi. 10.1002/mc.20052

By:

Ming Zhu;
Yuesheng Zhang;
Simon Cooper;
Ewa Sikorski;
John Rohwer;
G. Timothy Bowden

Publication type:

Article